Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03957603
Other study ID # 2017-KY-061-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 16, 2019
Est. completion date December 31, 2023

Study information

Verified date March 2024
Source Capital Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Gestational diabetes mellitus (GDM), GDM is the first time of gestational impaired glucose tolerance in pregnant women. It is the most common complication disease in women of childbearing age. It is associated with the high risk of adverse health outcomes for both mothers and offsprings and the variety of metabolic disease, including type 2 diabetes, etc. As for the epidemiology data of GDM in China, the prevalence is around 18% based on the criteria from the International Association of Diabetes in Pregnancy Study Groups, IADPSG. Several studies claimed that the diabetes-specific formula improved glycemic control in type 2 diabetes patients. However, the effects of medical nutrition therapy combined with the diabetes-specific formula in pregnant women with gestational diabetes mellitus (GDM) are unclear. Objective: This study examines whether medical nutrition therapy combined with Enteral Nutrition Suspension (TFP-DM, Diason 0.75 kcal/ml) in GDM women could improve the glycemic control and the pregnancy outcomes.


Description:

Design: A randomized controlled trial in pregnant women with gestational diabetes mellitus (GDM) will be performed at 24-28 weeks of gestation until the 42 days after delivery. Participants will be randomly assigned to the control group (Medical Nutrition Therapy) or the intervention group (Medical Nutrition Therapy combined with TFP-DM). The control group will receive the individualized Medical Nutrition Therapy, which focuses on restricting energy intake combined with behavioral lifestyle modification through participation in group sessions and individual counseling. The intervention group has two components. The first part has the same intervention with the control group. The second part has the additional Enteral Nutrition Suspension (TFP-DM, Diason 0.75 kcal/ml) intervention based on the standard Medical Nutrition Therapy. It meant 200ml/150Kcal TFP-DM will be suggested to participants in the intervention group 2 times per day. The 400ml TFP-DM will replace the 25 grams of grains and dairies during breakfast and the snack session after dinner. Overall, the control group and the intervention group will receive the same amount of carbohydrate and calorie intake. The primary outcome will be fasting plasma glucose concentration, HbA1c concentration. The secondary outcome will be serum glycated albumin, serum insulin concentration, the rate of using insulin for patients, the insulin sensitivity (HOMA-IS), the gestational weight gain, the incidence of macrosomic infants. Hypothesis: Medical nutrition therapy combined with the enteral nutrition suspension (TFP-DM, Diason 0.75 kcal/ml) in pregnant women with gestational diabetes mellitus (GDM) will improve in glucose and lipid metabolism and the relevant adverse pregnancy outcomes, and provide the evidence-based in clinical nutrition therapy for gestational diabetes mellitus (GDM) disease.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Gestational age between 24 and 28 weeks of gestation - Age >= 18 years - Singleton pregnancy - Two of three or three results of the oral glucose tolerance test (OGTT) are above the diagnostic criteria. (The diagnostic criteria for three results of OGTT: Fasting plasma glucose = 5.1mmol/L, 1-hour OGTT plasma glucose = 10.0mmol/L, 2-hour OGTT plasma glucose = 8.5mmol/L) Exclusion Criteria: - History of prenatal hypertension, diabetes, hyperlipidemias, liver disease, kidney disease, digestive tract disease and infectious disease (hepatitis, tuberculosis etc.) - Gestational weeks < 24 or > 28 - Age < 18 years or Age > 45 years - Multiple pregnancy - Food allergic history - Regular smoking, drinking alcohol - Patients with the history of using the assisted reproductive technology - Patients with psychiatric disorders that prevents correctly answer the questions - Patients who are unable to answer the questionnaire questions - Bariatric surgery history - Non-adherence of dietary and lifestyle recommendation - Threatened abortion

Study Design


Intervention

Dietary Supplement:
Enteral Nutrition Suspension (TFP-DM)
Individualized dietary and lifestyle intervention combined with the recommendation of Enteral Nutrition Suspension (TPF-DM, Diason 0.75 kcal/ml)
Behavioral:
Medical Nutrition Therpay
Individualized dietary and lifestyle intervention

Locations

Country Name City State
China Beijing Obstetrics and Gynecology Hospital,Capital Medical University Beijing

Sponsors (3)

Lead Sponsor Collaborator
Capital Medical University Nutricia Pharmaceutical Co., Ltd., Zhejiang University School of Medicine, Obstetrics and Gynecology Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in HbA1c from Baseline at 2 months Gestational age 24-28 weeks and 32-34 weeks and 36-40 weeks and 42-70 days after delivery
Primary Insulin treatmeant ratio From enrollment to delivery
Primary Change in serum glycated albumin from Baseline at 2 months Gestational age 24-28weeks and 32-34weeks and 36-40 weeks and 42-70days after delivery
Primary Change in fasting blood glucose concentration from Baseline at 2 months Gestational age 24-28 weeks and 32-34 weeks and 36-40 weeks and 42-70 days after delivery
Primary Change in Fasting insulin concentration from Baseline at 2 months Gestational age 24-28 weeks and 32-34 weeks and 36-40 weeks and 42-70 days after delivery
Secondary Oral glucose tolerance test Gestational age 24-28 weeks and 42-70 days after delivery
Secondary The insulin sensitivity (HOMA-IS) From enrollment to the 42 days after delivery
Secondary Gestational weight gain From enrollment to the 42 days after delivery
Secondary The incidence of macrosomia infants From enrollment to delivery
See also
  Status Clinical Trial Phase
Recruiting NCT06099574 - A Study on the Oral Health Status of Pregnant Women With Gestational Diabetes and Its Correlation With Oral Flora
Completed NCT02744300 - Balance After Baby Intervention for Women With Recent Gestational Diabetes N/A
Completed NCT02890693 - Improving Cardio-metabolic and Mental Health in Women With Gestational Diabetes Mellitus and Their Offspring N/A
Completed NCT02436551 - Gestational Diabetes in Central Asia: Prevalence and Management
Completed NCT02384226 - User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
Recruiting NCT02275845 - Medico-GDM Trial - Metformine to Prevent Gestational Diabetes Mellitus Phase 3
Recruiting NCT04621396 - The Next Generation Longitudinal Birth Cohort Diabetes Study
Completed NCT01916694 - Trial of Remote Evaluation and Treatment of Gestational Diabetes Mellitus N/A
Completed NCT01931280 - A Transgenerational e-Intervention for Gestational Diabetics and Their Offspring N/A
Not yet recruiting NCT01637727 - Long Term Effects of Gestational Diabetes Mellitus in a Population of Parous Women N/A
Completed NCT01565564 - Randomized Translational Study to Examine the Effects of Shared Care in Management of Gestational Diabetes N/A
Recruiting NCT00550979 - Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk N/A
Completed NCT00460018 - Diet, Exercise, and Breastfeeding Intervention Program for Women With Gestational Diabetes (DEBI Trial) Phase 2
Not yet recruiting NCT04915716 - Effect of Fasting Time Before Cesarean Section on Neonatal Blood Glucose in Pregnant Women With Gestational Diabetes Mellitus
Completed NCT04422821 - Flash Glucose Monitoring in Gestational Diabetes Mellitus: Study Protocol for a Randomized Controlled Trial N/A
Recruiting NCT04369313 - Effect of DCC on Neonatal Jaundice and Blood Gas Analysis in Infants Born to GDM Mothers N/A
Recruiting NCT05348863 - SPARK- a Digital Platform to Improve Self-management of Gestational Diabetes N/A
Recruiting NCT04272840 - The Impact of Glycemic Index Education on Lowering Dietary GI in Gestational Diabetes Mellitus N/A
Completed NCT02588729 - A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With GDM - RCT N/A
Completed NCT01922791 - Nutrition and Pregnancy Intervention Study N/A